Erenumab (Anti-CALCRL / CGRPR)
Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.
| Catalog Number | A2576 |
| CAS# | 1582205-90-0 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/erenumab-anti-calcrl-cgrpr.html |